Retatrutide is a newly developed medication that acts as a powerful GLP-1 receptor activator. This breakthrough method holds significant promise for controlling type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide improves insulin secretion and limits glucagon release, leading to improved glucose control. Clinical trials have dem